Andrew Hadd

Andrew Hadd, PhD, MBA has a diverse work experience in the fields of genomics, healthcare, and technology transfer. Andrew currently works at Invitae as the Director of Innovation & Strategic Partnerships, where they develop strategies for the commercial offering of a real-world data platform and leads the development of drug discovery strategic partnerships. Previously, they held roles at ArcherDX, CU Innovations, Rare Genomics Institute, and Oregon Health and Science University, where they focused on venture development, strategic alliances, and partnership management. Andrew also has experience in clinical research, genetic testing, and academia. Andrew holds a PhD in biochemistry and an MBA, and has a strong background in business and entrepreneurship.

Andrew Hadd, PhD, MBA has a diverse education history. Andrew earned a Bachelor of Arts and Sciences degree in Biochemistry from the University of Colorado Boulder in 2009. In 2011, they completed their Ph.D. in Biochemistry and Molecular Biology from Oregon Health & Science University. In 2013, they obtained a Certificate in Technology Entrepreneurship from the University of Portland Pamplin School of Business, specializing in Entrepreneurship/Entrepreneurial Studies. Andrew recently added an MBA degree to their credentials, completing it in 2020 at the Quantic School of Business and Technology. There is no information provided about their education at UC Santa Barbara in 2009.